Anticancer Therapies – Multimedia

Just as every patient is individual, so is their cancer – even the cells within a specific tumor can vary considerably from one another. In this infographic, we explore cancer heterogeneity and the tumor microenvironment, discover the challenges faced when designing anticancer drugs, and uncover different therapeutic strategies for treating the disease.

In this app note, discover how phenotypic screening addresses these needs of rapidly and reliably profiling T cell activation and health.

There have been many exciting developments in the biopharma research field this year. Here, we revisit the top 10 most-read news stories of 2019 at Technology Networks.

This list outlines the new molecular entities (NMEs) and new therapeutic biological products approved by the FDA’s Center for Drug Evaluation and Research (CDER) during 2019.

Discover how chemotherapy drugs use cytotoxic agents to attack cancer cells and the impact they have on your body.

2019 has been an exciting year for the cancer research field. This list details the top 10 most-read news stories from the field this year, published on Technology Networks.

This listicle explores the five different types of immunotherapy, how each type works, and takes a closer look at some examples of approved immunotherapies.

Download this handbook to advance your understanding of how cell culture models can drive breakthroughs in these areas of cancer research.

In a talk about a breakthrough, CAR T-cell therapy pioneer, Carl June shares how three decades of research culminated in a therapy that's eradicated cases of leukemia once thought to be incurable – and explains how it could be used to fight other types of cancer.

Researchers are developing third generation CAR-T immunotherapy treatments which aim to be more effective with less side effects than previous therapies.